# US 2006/0153931 A1 · Prevention of flap necrosis in plastic surgery

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0153931 A1
- Document ID: US20060153931A1
- Status: Published application
- Kind: A1
- Application number: 10/521,394
- Filed: 2002-12-02
- Published: 2006-07-13
- Earliest claimed: 2001-12-06
- Inventors: Jonathan Stamler; Michael Zenn; Eric Toone
- Web page: https://patentgrep.com/patent/US20060153931A1

## CPC

- A61K 31/724: Cyclodextrins
- A61K 31/04: Nitro compounds
- A61K 31/095: Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K 31/21: Esters, e.g. nitroglycerine, selenocyanates
- A61K 33/00: Medicinal preparations containing inorganic active ingredients
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61P 3/10: for hyperglycaemia, e.g. antidiabetics
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 9/08: Vasodilators for multiple indications
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 9/12: Antihypertensives
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

NO, NO donor or prodrug that causes formation of nitrosothiol in tissue optionally in combination with lidocaine is topically applied to pedicle of a pedicle flap or other source of blood supply to prevent necrosis in pedicle flap or in any microvascular surgery. Composition containing drug is formulated with nitrosylated polythiolated cyclodextrin to improve drug delivery.

## Claims

### Claim 1

A method for preventing necrosis in a pedicle flap or in any microvascular surgery comprising topically applying to pedicle or other source of blood supply, a therapeutically effective amount of vasodilator composition containing NO or NO donor or prodrug that causes formation of nitrosothiol in tissue, optionally in combination with lidocaine.

### Claim 2 (depends on 1)

The method of claim 1 where the vasodilator composition contains alkyl nitrite of molecular weight up to 10,000.

### Claim 3 (depends on 2)

The method of claim 2 where the alkyl nitrite is ethyl nitrite.

### Claim 4 (depends on 1)

The method of claim 1 where the vasodilator composition contains an S— nitrosothiol.

### Claim 5 (depends on 4)

The method of claim 4 where the S-nitrosothiol is cyclodextrin NO.

### Claim 6 (depends on 1)

The method of claim 1 where the vasodilator composition contains a metal nitrosyl.

### Claim 7

A method for delivering a drug comprising incorporating the drug in a gel or in a solution or in a pharmaceutical base, containing from 1 μM to 100 μM nitrosylated polythiolated cyclodextrin or other nitrosylated polymer or long lived gel coating equivalent exemplified by cyclodextrin or coating the drug in pill form with a coating that delivers nitric oxide, and administering the resulting drug containing composition topically to the skin or topically to the gastrointestinal tract.

### Claim 8 (depends on 7)

The method of claim 7 where the drug is incorporated in a therapeutically effective amount in a gel containing from 1 μM to 100 mM nitrosylated polythiolated cyclodextrin.
